TradingView
RocketTickers
Oct 17, 2018 4:22 PM

Eiger BioPharmaceuticals Announces Positive Results in Phase 2  Long

NASDAQ:EIGR1D

Description

⋅
EIGR: Eiger BioPharmaceuticals, Inc.
2018-10-16 16:05:00
Eiger BioPharmaceuticals Announces Positive Results in Phase 2 PREVENT Study of Avexitide Targeting GLP-1 in Post-Bariatric Hypoglycemia (PBH)
Beyond Technical Analysis
More